首页> 外文期刊>Japanese journal of clinical oncology. >Development of Respiratory Motion Reduction Device System (RMRDs) for Radiotherapy in Moving Tumors.
【24h】

Development of Respiratory Motion Reduction Device System (RMRDs) for Radiotherapy in Moving Tumors.

机译:开发用于运动性肿瘤放射治疗的呼吸运动减少设备系统(RMRD)。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The internal target volume (ITV) for tumors in the abdomen or thorax includes sufficient margin for breathing-related movement of tumor volumes during treatment. Depending on the location of the tumor, the magnitude of the ITV margin extends from 1 to 3 cm, which increases substantially the volume of the irradiated normal tissue, hence resulting in an increase in normal tissue complication probability (NTCP). We developed a simple and handy method which can reduce ITV margins in patients with moving tumors: the respiratory motion reduction device system (RMRDs). METHODS: The patient's clinical database was structured for moving tumor patients and patient set-up error measurement and immobilization device effects were investigated. The system is composed of the respiration presser device (RPD) utilized in the prone position and the abdominal strip device (ASD) utilized in the supine position, and the analysis program, which enables analysis of patient set-up reproducibility. It was tested for analyzing the diaphragm movement from patients with RMRDs, the magnitude of the ITV margin was determined and the dose-volume histogram (DVH) was computed using treatment planning software. The dose to normal tissue in patients with and without RMRDs was analyzed by comparing the fraction of the normal liver receiving 50% of the isocenter dose. RESULTS: Average diaphragm movement due to respiration was 16 +/- 1.9 mm in the case of the supine position, and 12 +/- 1.9 mm in the case of the prone position. When utilizing the RMRDs, which was personally developed in our hospital, the value was reduced to 5 +/- 1.4 mm, and in the case in which the belt immobilization device was utilized, the value was reduced to 3 +/- 0.9 mm. In the case where the strip device was utilized, the value was proven to reduce to 4 +/- 0.3 mm. As a result of analyzing the volume of normal liver where 50% of the prescription dose is irradiated in DVH according to the radiation treatment planning, the use of the RMRD can create a reduction of 30% to the maximum. Also by obtaining the digital image, the function of comparison between the standard image, automated external contour subtraction, etc. was utilized to develop a patient set-up reproducibility analysis program that can evaluate the change in patient set-up. CONCLUSION: Internal organ motion due to breathing can be reduced using RMRDs, which is simple and easy to use in the clinical setting. It can reduce the organ motion-related planning target volume margin, thereby decreasing the volume of irradiated normal tissue.
机译:背景:腹部或胸部肿瘤的内部目标体积(ITV)具有足够的余量,可以在治疗过程中进行与呼吸有关的肿瘤体积的运动。根据肿瘤的位置,ITV边缘的大小会从1厘米扩展到3厘米,这会大大增加被照射的正常组织的体积,从而导致正常组织并发症发生率(NTCP)的增加。我们开发了一种简便易用的方法,可以减少运动中的肿瘤患者的ITV边缘:呼吸运动减少设备系统(RMRD)。方法:构建用于移动肿瘤患者的患者临床数据库,并研究患者设置误差的测量和固定装置的效果。该系统由俯卧位使用的呼吸加压器(RPD)和仰卧位使用的腹带装置(ASD)以及分析程序组成,该程序可以分析患者的可重复性。测试了该系统以分析RMRD患者的the肌运动,确定了ITV边缘的幅度,并使用治疗计划软件计算了剂量-体积直方图(DVH)。通过比较接受50%等中心点剂量的正常肝脏的比例,分析有无RMRD的患者对正常组织的剂量。结果:仰卧位情况下由于呼吸引起的平均diaphragm肌运动为16 +/- 1.9 mm,俯卧位情况下为12 +/- 1.9 mm。当使用我们医院亲自开发的RMRD时,该值减小到5 +/- 1.4毫米,而在使用皮带固定装置的情况下,该值减小到3 +/- 0.9毫米。在使用剥离装置的情况下,该值被证明减小至4 +/- 0.3mm。根据放射治疗计划分析了在DVH中照射了50%处方剂量的正常肝脏的体积后,使用RMRD最多可以减少30%。同样通过获得数字图像,利用标准图像之间的比较功能,自动外部轮廓扣除等来开发可评估患者设置变化的患者设置可重复性分析程序。结论:使用RMRD可以减少由于呼吸引起的内脏器官运动,这在临床环境中简单易用。它可以减少与器官运动有关的计划目标体积的余量,从而减少照射的正常组织的体积。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号